Shipton Edward A, Shipton Elspeth E, Shipton Ashleigh J
Department of Anaesthesia, University of Otago, Christchurch, New Zealand.
Pain Ther. 2018 Jun;7(1):23-36. doi: 10.1007/s40122-018-0096-7. Epub 2018 Apr 6.
The opioid epidemic, with its noticeable increase in opioid prescriptions and related misuse, abuse and resultant deaths in the previous 12 years, is a particularly North American phenomenon. Europe, and particularly low- and middle-income countries, appear to be less influenced by this problem. There is undisputable value in using opioids not only in the treatment of acute pain, but in cancer pain as well. However, opioids are progressively being prescribed more and more for chronic non-cancer pain, despite inadequate data on their efficacy. In this paper, we describe the current prevalence of opioid misuse in a number of countries and the rationale for the commencement of opioid therapy. The safe initiation and monitoring of opioid therapy as well as the need for concurrent use of interdisciplinary multimodal therapy is discussed. The possible consequences of long-term use and predictors of high opioid use and overdose are presented. In particular, the management of opioid use disorders and the prevention of opioid abuse and dependence in the young, the old and the pregnant are discussed. Measures to prevent overprescribing and to alleviate risk are described, including the tapering of opioids and the use of opioid deterrents. Finally, the paper looks at the future development of pioneering medications and technologies to potentially treat abuse. In those parts of the world with an opioid epidemic, coroners and medical examiners, private and public health agencies, and agencies that enforce the law need to cooperate in an effort to slow down and reverse the indiscriminate use of prescribing opioids in the long-term for chronic non-cancer pain. Ongoing research is needed to create ways to minimise risks of opioid use, and to provide evidence for effective strategies for treating chronic pain.
在过去12年中,阿片类药物流行导致阿片类药物处方显著增加,以及相关的误用、滥用和死亡,这是一个特别的北美现象。欧洲,尤其是低收入和中等收入国家,似乎受这个问题的影响较小。使用阿片类药物不仅在治疗急性疼痛方面有不可争议的价值,在治疗癌症疼痛方面也是如此。然而,尽管关于其疗效的数据不足,但阿片类药物越来越多地被用于治疗慢性非癌性疼痛。在本文中,我们描述了一些国家目前阿片类药物滥用的流行情况以及开始阿片类药物治疗的基本原理。讨论了阿片类药物治疗的安全启动和监测以及同时使用跨学科多模式治疗的必要性。介绍了长期使用的可能后果以及高阿片类药物使用和过量的预测因素。特别讨论了阿片类药物使用障碍的管理以及在年轻人、老年人和孕妇中预防阿片类药物滥用和依赖的问题。描述了防止过度开处方和减轻风险的措施,包括逐渐减少阿片类药物用量和使用阿片类药物威慑剂。最后,本文探讨了可能用于治疗滥用问题的开创性药物和技术的未来发展。在世界上存在阿片类药物流行的地区,验尸官和法医、私营和公共卫生机构以及执法机构需要合作,长期努力减缓并扭转长期不加区别地为慢性非癌性疼痛开阿片类药物的情况。需要持续开展研究,以找到将阿片类药物使用风险降至最低的方法,并为治疗慢性疼痛的有效策略提供证据。